LPL Financial’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,708
Closed -$15.8K 5466
2024
Q4
$15.8K Sell
1,708
-542
-24% -$7.97K ﹤0.01% 5222
2024
Q3
$37K Sell
2,250
-250
-10% -$4.6K ﹤0.01% 5030
2024
Q2
$47.7K Buy
2,500
+250
+11% +$4.86K ﹤0.01% 4842
2024
Q1
$60.2K Buy
2,250
+997
+80% +$17.2K ﹤0.01% 4748
2023
Q4
$17.1K Buy
+1,253
New +$18.2K ﹤0.01% 4740

Other funds holding NXTC

LPL Financial's NXTC Position: Q1 2025 in Review

LPL Financial sold out of NextCure (NXTC) in Q1 2025, closing a stake of 1,708 shares — an estimated $15.8K sold.

LPL Financial first reported a position in NXTC in Q4 2023 and held it in 5 quarters. The position peaked at $60.2K in Q1 2024. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

  • LPL Financial reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
  • LPL Financial sold 1,708 NextCure shares in Q1 2025, an estimated $15.8K.
  • LPL Financial first reported a position in NextCure in Q4 2023 and held it in 5 quarters.
  • LPL Financial's NextCure position peaked at $60.2K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on LPL Financial's 13F filing for Q1 2025, filed 7 May 2025.